Literature DB >> 11710515

Mapping of the interaction domain of the protein kinase CKII beta subunit with target proteins.

B H Ahn1, T H Kim, Y S Bae.   

Abstract

Protein kinase CKII is composed of two catalytic (alpha or alpha') subunits and two regulatory (beta) subunits. The CKIIbeta subunit is thought to mediate the tetramer formation and interact with other target proteins. Previously we have shown that CKIIbeta interacts with ribosomal proteins L5 and L41, DNA topoisomerase IIbeta, and SAG/CKBBP1. In this study, the two-hybrid system was used to define the subregions of CKIIbeta that are involved in the interaction with L5, L41, topoisomerase IIbeta, SAG/CKBBP1, and unknown proteins, CKBBP2 and CKBBP3. The results indicated that the region between residues 1 and 167 of CKIIbeta is common binding site for L5, topoisomerase IIbeta, SAG/CKBBP1, and L41. The region between amino acids 19 and 167 of CKIIbeta is sufficient for the interaction with CKBBP3. The region between residues 67 and 130 of CKIIbeta is a minimal fragment that is required for interaction with CKBBP2. Overlay experiments showed that the region between residues 1 and 167 of CKIIbeta interacts with L5, L41, and SAG/CKBBP1 in vitro. These results suggest that the binding sites of CKIIbeta for these target proteins are not located within a small linear sequence stretch, but rather are created by a three-dimensional structure.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11710515

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  5 in total

Review 1.  DNA topoisomerase II and its growing repertoire of biological functions.

Authors:  John L Nitiss
Journal:  Nat Rev Cancer       Date:  2009-04-20       Impact factor: 60.716

2.  Ability of CK2beta to selectively regulate cellular protein kinases.

Authors:  Birgitte B Olsen; Barbara Guerra
Journal:  Mol Cell Biochem       Date:  2008-06-17       Impact factor: 3.396

3.  Mechanism of androgen receptor corepression by CKβBP2/CRIF1, a multifunctional transcription factor coregulator expressed in prostate cancer.

Authors:  Jiann-An Tan; Suxia Bai; Gail Grossman; Mark A Titus; O Harris Ford; Elena A Pop; Gary J Smith; James L Mohler; Elizabeth M Wilson; Frank S French
Journal:  Mol Cell Endocrinol       Date:  2013-10-05       Impact factor: 4.102

4.  Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.

Authors:  Rohit Moudgil; Gursharan Samra; Kyung Ae Ko; Hang Thi Vu; Tamlyn N Thomas; Weijia Luo; Jiang Chang; Anilkumar K Reddy; Keigi Fujiwara; Jun-Ichi Abe
Journal:  Front Cardiovasc Med       Date:  2020-11-06

Review 5.  TOP2B: The First Thirty Years.

Authors:  Caroline A Austin; Ka C Lee; Rebecca L Swan; Mushtaq M Khazeem; Catriona M Manville; Peter Cridland; Achim Treumann; Andrew Porter; Nick J Morris; Ian G Cowell
Journal:  Int J Mol Sci       Date:  2018-09-14       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.